Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Why: Its new diagnostics exploit a growing understanding of the molecular basis of cancer.
Key innovation: It has developed a comprehensive cancer diagnostic test and is partnering with pharmaceutical companies to use the test in drug development.
Foundation Medicine is offering a test that helps oncologists choose drugs targeted to the genetic profile of a patient's tumor cells. Has personalized cancer treatment finally arrived?
By Adrienne Burke
The FDA plans to overhaul its regulation of the increasingly common diagnostic tests.
By Emily Singer
Headquarters: Cambridge, Massachusetts
Founded: 2010
Funding Raised: $33.5 million
